Callan Family Office LLC lowered its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 43.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 9,801 shares of the financial services provider's stock after selling 7,549 shares during the period. Callan Family Office LLC's holdings in Aflac were worth $1,090,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Brighton Jones LLC lifted its stake in Aflac by 64.4% during the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider's stock worth $1,507,000 after purchasing an additional 5,708 shares during the last quarter. FMR LLC lifted its stake in Aflac by 0.9% during the fourth quarter. FMR LLC now owns 1,213,449 shares of the financial services provider's stock worth $125,519,000 after purchasing an additional 11,345 shares during the last quarter. Sagespring Wealth Partners LLC bought a new position in Aflac during the fourth quarter worth $647,000. Advisors Capital Management LLC lifted its stake in Aflac by 6.9% during the fourth quarter. Advisors Capital Management LLC now owns 11,030 shares of the financial services provider's stock worth $1,141,000 after purchasing an additional 711 shares during the last quarter. Finally, Savvy Advisors Inc. lifted its stake in Aflac by 4.4% during the fourth quarter. Savvy Advisors Inc. now owns 3,230 shares of the financial services provider's stock worth $334,000 after purchasing an additional 136 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.
Insiders Place Their Bets
In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $102.57, for a total value of $102,570.00. Following the completion of the transaction, the director owned 25,105 shares in the company, valued at $2,575,019.85. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director owned 70,992 shares of the company's stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.90% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have weighed in on AFL shares. Evercore ISI reaffirmed an "underperform" rating and issued a $106.00 target price (up from $105.00) on shares of Aflac in a research report on Thursday. Raymond James Financial dropped their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research report on Thursday, May 29th. Barclays set a $98.00 target price on Aflac and gave the stock an "underweight" rating in a research report on Monday, July 7th. Keefe, Bruyette & Woods increased their target price on Aflac from $106.00 to $108.00 and gave the stock a "market perform" rating in a research report on Monday. Finally, Wall Street Zen raised Aflac from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $108.54.
Get Our Latest Stock Analysis on Aflac
Aflac Price Performance
NYSE:AFL traded up $0.05 during mid-day trading on Friday, reaching $105.35. 2,645,887 shares of the stock were exchanged, compared to its average volume of 2,172,469. The business has a fifty day moving average price of $102.53 and a 200 day moving average price of $104.87. The firm has a market capitalization of $56.34 billion, a PE ratio of 23.89, a PEG ratio of 2.97 and a beta of 0.83. Aflac Incorporated has a 1-year low of $96.95 and a 1-year high of $115.50. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.33.
Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Tuesday, August 5th. The financial services provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.07. The firm had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 15.08% and a net margin of 15.32%. Aflac's revenue was down 19.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.83 earnings per share. Research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Aflac announced that its Board of Directors has approved a share buyback program on Tuesday, August 12th that allows the company to buyback 100,000,000 shares. This buyback authorization allows the financial services provider to purchase shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.
Aflac Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th will be given a $0.58 dividend. The ex-dividend date is Wednesday, August 20th. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.2%. Aflac's dividend payout ratio (DPR) is 52.61%.
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report